Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Background Despite the prophylactic use of allopurinol, tumor lysis syndrome (TLS)-related morbidity and mortality still occur in a number of patients with acute myeloid leukemia (AML). The aim of this study was: (i) to analyze the incidence and outcome of TLS in a large series of patients with AML...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Pau Montesinos, Ignacio Lorenzo, Guillermo Martín, Jaime Sanz, Maria Luz Pérez-Sirvent, David Martínez, Guillermo Ortí, Lorenzo Algarra, Jesus Martínez, Federico Moscardó, Javier de la Rubia, Isidro Jarque, Guillermo Sanz, Miguel A. Sanz
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Ferrata Storti Foundation 2008-01-01
Серія:	Haematologica
Онлайн доступ:	https://haematologica.org/article/view/4719
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Схожі ресурси